Pourabbas B, Ziyaeyan M, Alborzi A, Mardaneh J. Efficacy of measles and rubella vaccination one year after the nationwide campaign in Shiraz, Iran.
Int J Infect Dis 2007;
12:43-6. [PMID:
17950020 DOI:
10.1016/j.ijid.2007.03.013]
[Citation(s) in RCA: 10] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/01/2006] [Revised: 02/24/2007] [Accepted: 03/01/2007] [Indexed: 11/26/2022] Open
Abstract
BACKGROUND
The World Health Organization target for measles elimination in the Eastern Mediterranean Region was established in 2010. In Iran, the national measles-rubella campaign, targeting individuals aged 5-25 years, was initiated in December 2003.
METHODS
To evaluate the impact of the campaign after one year, 909 serum samples were collected in Shiraz, southern Iran, from a population aged 6-26 years, divided into five groups according to age. IgG antibodies were tested using ELISA for the measles and rubella antibodies, and the plaque reduction neutralization test (PRNT; measles) was used for samples with equivocal results.
RESULTS
Measles protective immunity reached 80.6%, 72.7%, 84.9%, and 87.5% and rubella immunity reached 91.0%, 99.6%, 99.6%, and 97.0% for the age groups 6-10, 11-15, 16-20, and 20-26 years, respectively. Seropositivity to the rubella virus in this population was high, especially in women of childbearing age (98.9%), thereby preventing congenital rubella infections. However for measles, it was significantly lower than the rate required to achieve >or=95% coverage for elimination.
CONCLUSIONS
These data indicate that an increase in immunization coverage by supplementary administration of a second dose of measles vaccine is needed to interrupt the endemic transmission of the measles virus.
Collapse